However, it will take up to 48 hours to process this form, A PDA will not be issued or the eligibility check will not be successful if the patient is not enrolled in the Clozapine REMS Program, if an ANC is not on file, or if a patient has an ANC that indicates moderate or severe neutropenia (without a prescriber Treatment Rationale), Pharmacies may still enroll patients in the Clozapine REMS Program by calling the Clozapine REMS Program Contact Center at 844-267-8678, Because there are technical problems with the system that have not yet been resolved, we encourage adherence to the requirements though the absence of prescriber and pharmacy certification will not preclude a patient being dispensed clozapine, ANC not current (i.e. 0000031903 00000 n
0000067666 00000 n
The authorized representative will be responsible for recertifying the pharmacy. This information contains a summary of important points and is not an exhaustive review of information about the medication. FDA Response:We would like to listen to your thoughts on proposed changes to the pharmacy classification system. 4301 Wilson Blvd., Suite 300 Total percentage of neutrophils* obtained from the differential. Your doctor will inform you whether these changes will affect your scheduled blood work. If these symptoms occur, contact your health care provider immediately. Health care professionals continue to alert FDA about ongoing difficulties with theClozapine REMS program, including a high call volume and long call wait times for stakeholders since launch of the program on November 15, 2021. Always seek the advice of a physician or other qualified medical professional with any questions you may have regarding medications or medical conditions. Prescribers and pharmacies must be certified by February 28, 2019 or they will no longer be able to prescribe/dispense clozapine. The FDA would like to continue our communication with you and will be setting up meetings in early December to gather feedback on the implementation. 0000015584 00000 n
Starting December 14, 2015, outpatient pharmacies will be required to obtain a pre-dispense authorization (PDA) from the Clozapine REMS Program before clozapine can be dispensed. 0000005119 00000 n
The site is secure. 0
You will be taken to the new. If an overdose occurs call your doctor or 911. Clozapine may also help reduce the risk of repeated suicidal behavior in patients with schizophrenia or schizoaffective disorder. This has resulted in patient access issues in some cases. Additional, new and favorable statements in the letter include: CPNP and its advocacy partners met with the FDA again on December 16. The FDA says that this a carryover policy. A3. The most common side effects of clozapine include constipation, drooling, sleep problems, and weight gain. A decrease in white blood cells increases the risk of infection. An official website of the United States government, : Clozapine is an FDA-approved atypical antipsychotic medication for treatment-resistant schizophrenia. If you need to prescribe clozapine but are, Enroll patients in the Clozapine REMS Program. People living with schizophrenia who wish to become pregnant face important decisions. Due to ongoing implementation challenges with the new Clozapine REMS Program, FDA is extending the November 23, 2015 prescriber certification deadline and the December 14, 2015 pharmacy certification deadline to help ensure that health care professionals have sufficient time to complete this process and that patient access to clozapine is maintained. Less than 1% of patients taking clozapine may develop a condition called agranulocytosis, Agranulocytosis causes the body to make fewer white blood cells. Contact your health care provider right away if these symptoms occur. rhythmic movement of the muscles. 0000047134 00000 n
FDA Response:We will continue to monitor the transition of the REMS and determine if the 90 day transition period post-implementation of the modified Clozapine REMS, needs to be extended. Pharmacists dispense clozapine without a REMS dispense authorization (RDA). Severe and life-threatening hepatotoxicity (liver damage) has been reported in patients taking clozapine. All other programs and services are trademarks of their respective owners. Click on the link in the Important Program Update. within 7, 15, or 31 days of the dispense date) based on the patients monitoring frequency (MF), Although not required, pharmacies are encouraged to contact the prescriber to acquire the most recent patient ANC information for patient safety purposes. Do not put tablets in a pillbox if you take the orally disintegrating tablets. 0000003289 00000 n
We will probably not find out until Monday, November 15, 2021. Before sharing sensitive information, make sure you're on a federal government site. This form must be submitted monthly. Only your health care provider can determine the correct dose for you. xref
TD symptoms include slow or jerky movements that one cannot control, often starting in the mouth with tongue rolling or chewing movements. While all medications have labeling that informs health care stakeholders about medication risks, only a few medications require a REMS. Health care professionals shoulduse their clinical judgmentwith regard toprescribing and dispensing clozapine to patients with anabsolute neutrophil count (ANC)within the acceptable range. Meanwhile, the prescriber uses the "Manage Personnel" button on the prescriber page to deal with their designees. These credentials will only work on the modified Clozapine REMS website. New Patient Status Form to document monitoring for all outpatients. At the meeting, CPMG discussed a 90-day transition period. Other non-medication treatment you are receiving, such as talk therapy or substance abuse treatment. You will be taken to the new Clozapine REMS website. Tell your doctor if any of these symptoms are severe or do not go away: drowsiness. A specific treatment to reverse the effects of clozapine does not exist. Copyright 2021 NAMI. 2003-2023 aapp.org | All Rights Reserved | Terms of Use | Contact. = The pharmacy must have a copy of your blood counts to be able to dispense the medication. Patients will continue to have blood tests (ANC monitoring). Additional information is available through the following FDA and CPNP resources: On February 14, CPNP joined 6 other national association partners in authoring a letterurging the Food and Drug Administration (FDA) to continue the temporary suspension of the Clozapine REMS (set to expire on 2/17) and provide an update on the Clozapine Risk Evaluation and Mitigation Strategies (REMS) implementation. Learn more about these changes and how to avoid treatment interruption during the transition to this new system. Inpatient prescribers are not required to be certified if they are prescribing for patients already enrolled in the program, If a patients absolute neutrophil count (ANC) is not current, this will not prevent clozapine from being dispensed, and. The following medications may increase the risk of heart problems when used with clozapine: The following medications may increase the levels and effects of clozapine: ciprofloxacin (Cipro), fluvoxamine (Luvox) and lamotrigine (Lamictal) Q8eo{^. trouble with speaking. Clozapine rebalances dopamine and serotonin to improve thinking, mood, and behavior. If would be helpful if you could describe the difficulties with pharmacists serving as designees and prescribers serving as designees for other prescribers, so we can explore ways to address this. Clozapine is the medication of choice for those with treatment-resistant schizophrenia. 0000165078 00000 n
0000002026 00000 n
Re-certification of pharmacies must be done with the revised Clozapine REMS materials. Never delay seeking professional medical advice or disregard medical professional advice as a result of any information provided herein. Your provider can explain how these different treatments work with the medication. Clozapine is a psychiatric medication and is the first atypical antipsychotic (also called second-generation antipsychotic). Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. Cigarette smoke can decrease levels of clozapine by as much as 50%. [Updated 7/29/21] CPMG and FDA continue to work to ensure that patients relying on clozapine have continued access to this medication and appropriate management of associated risks. Discuss this with your health care provider. Clozapine is an antipsychotic drug used to treat schizophrenia in patients whose symptoms are not controlled with standard treatment. 2022 The American Association of Psychiatric Pharmacists (AAPP) and the National Alliance on Mental Illness (NAMI). If your pharmacy dispenses clozapine and is. We will communicate the revised certification deadlines and additional information about the PDA launch as soon as possible. Continue prescribing and dispensing clozapine to patients with an absolute neutrophil count (ANC) within the acceptable ranges while the issues are being resolved. This will allow designees to initiate enrollment and the ability for a designee to associate with multiple prescribers. Myocarditis (inflammation of heart muscle) and cardiomyopathy (enlarged heart) have rarely been reported. 0000046877 00000 n
Obtain a REMS Dispense Authorization (RDA) prior to each dispense utilizing either the REMS website or calling the REMS Contact Center. The authorization to dispense will be obtained either through the contact center or online via the REMS website. BEN is more common in men, Before starting clozapine baseline ANC must be, at least 1500/micro L in general population A5. If you have questions or concerns about the Clozapine REMS Program or its website, please contact FDA at druginfo@fda.hhs.gov , 1-855-543-3784 or 301-796-3400. If you have questions or concerns about the Clozapine REMS Program or its website please contact FDA at druginfo@fda.hhs.gov, 1-855-543-3784 or 301-796-3400. 0000013899 00000 n
2dxdt5x+dydt=etdxdtx+dydt=5et\begin{array}{l}{2 \frac{d x}{d t}-5 x+\frac{d y}{d t}=e^{t}} \\ {\frac{d x}{d t}-x+\frac{d y}{d t}=5 e^{t}}\end{array} Increased heart rate, low blood pressure, high blood pressure, drowsiness, sedation, dizziness, headache, insomnia, vertigo, increased salivation, sweating, visual disturbance, weight gain, constipation, nausea, vomiting, indigestion, fever, Decreased white blood cells, inflammation of heart muscle, seizures, severely low blood pressure, urinary incontinence. Effective November 15, 2021, the Clozapine REMS requires: For prescribers who prescribe for outpatient use or prescribers who are initiating treatment inpatient: For pharmacies that dispense clozapine for outpatient use: For pharmacies that dispense clozapine for inpatient use: For additional information about the Clozapine REMS, please call the Clozapine REMS Contact Center at 844-267-8678 or visit www.clozapinerems.com. Authorized representatives must create new log-in credentials. We are working closely with the Clozapine REMS program administrators to address these challenges and to avoid interruptions in patient care. Information on healthy eating and adding exercise to decrease your chances of developing metabolic syndrome may be found at the following sites: http://www.helpguide.org/articles/healthy-eating/healthy-eating.htm, http://www.helpguide.org/home-pages/exercise-fitness.htm. CPNP has taken a leading role in addressing the challenges of this new Clozapine REMS. Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, and dehydration. We encourage pharmacists and prescribers to continue working with the Clozapine REMS to complete certification and patient enrollment. Continuity of care, patient access to clozapine, and patient safety are our highest priorities. You may need urgent medical care. Symptoms of EPS include restlessness, tremor, and stiffness. With input from you, your health care provider will assess how long you will need to take the medication. Depending on the patients monitoring frequency, this could require daily, weekly, biweekly, or monthly documentation of the ANC. Pharmacies with multiple locations must certify on behalf of each pharmacy location, and add each pharmacy location as that pharmacy completes the necessary training. 0000032016 00000 n
restlessness. We encourage pharmacists and prescribers to continue working with the Clozapine REMS to complete certification and patient enrollment. Obtain an absolute neutrophil count (ANC) for patients in accordance with the clozapine Prescribing Information and aligned with the patients monitoring frequency. In order to reduce the burden on prescribers and minimize unintended treatment interruption for patients, the documentation of ANC will now be submitted monthly. hb``f``3c`c` 11. Your doctor may order an EKG to monitor for irregular heartbeat. Although there were multiple causes of death in studies, most deaths appeared to be due to cardiovascular causes (e.g. FDA is aware health care professionals and patients continue to experience ongoing difficulties with the Clozapine REMS program, including issues with patient access to clozapine for patients recently discharged from an inpatient setting. Stakeholders concluded by reiterating that the transition to the new clozapine REMS has placed unjustified burdens on health care providers and health care systems and continued requirements of questionable effectiveness. The authorization to dispense clozapinecanbe obtained either through the contact center or online via the REMS website. If you have questions or concerns about the Clozapine REMS Program or its website, please contact FDA atdruginfo@fda.hhs.gov, 1-855-543-3784 or 301-796-3400. Do not stop taking clozapine, even when you feel better. Are encouraged to submit ANCs to the Clozapine REMS Program when the pharmacist is made aware of a more current ANC. FDA takes these concerns seriously. Beginning November 15, 2021, the current switch system or pharmacy management system that is currently usedas an optionto verifysafe use conditions for clozapine will be removed. 0000032389 00000 n
dizziness, feeling unsteady, or having trouble keeping your balance. 0000003246 00000 n
[Updated 11/02/2022] FDA is temporarily exercising additional enforcement discretion with respect to certain Clozapine REMS program requirements to ensure continuity of care for patients taking clozapine. %%EOF
FDA Response:Inpatient pharmacies only being able to dispense a seven-day supply of medication upon discharge was carried over from the current program that has been in effect since 2015. As part of our ongoing dialogue with the FDA regarding the New Clozapine REMS (NCR), we have received further guidance on the issue of prescriber designees. Patient enrollment in the Clozapine REMS Program is confirmed, You can enroll patients through your account on, If the patient is not enrolled in the Clozapine REMS Program, a dispense will not be authorized, ANCs should be submitted directly to the REMS Program and not to the pharmacy to ensure timely data entry into the system, ANCs may be submitted to the program by logging into your account on, ANCs may also be submitted using the ANC reporting form (available under the Resources tab on, If a patient does not have an ANC on file with the REMS, a dispense, If the last ANC on file for a patient indicates moderate or severe neutropenia, a dispense, A patient with an ANC that indicates moderate or severe neutropenia must have a Treatment Rationale on file before the dispense can be authorized, A Treatment Rationale can be submitted by logging into your account at, The ANC reporting form can also be used to submit a Treatment Rationale. Effective February 28, 2019, the Clozapine REMS Program requirements are: For additional information about the Clozapine REMS Program, please call the Clozapine REMS Program Contact Center at 844-267-8678 or visit www.clozapinerems.com. [Updated 12/2/2021] Healthcare professionals continue to alertFDAabout ongoingdifficulties with theClozapine REMS program,including a high call volumeandlong call wait timesfor stakeholderssincelaunchof theprogram onNovember 15, 2021. If you are pregnant, plan to become pregnant, or are breastfeeding, If you smoke, drink alcohol, or use illegal drugs, Antipsychotics, such as chlorpromazine (Thorazine), thioridizine (Mellaril), iloperidone (Fanapt), asenapine (Saphris) paliperidone (Invega), quetiapine (Seroquel), ziprasidone (Geodon), Antiarrhythmics (heart rhythm medications), such as procainamide, quinidine, amiodarone (Cordarone), dronedarone (Multaq), sotalol (Betapace), Hallucinations, disorganized thinking, and delusions may improve in the first 1-2 weeks, Sometimes these symptoms do not completely go away, Motivation and desire to be around other people can take at least 1-2 weeks to improve, Symptoms continue to get better the longer you take clozapine, It may take 2-3 months before you get the full benefit of clozapine. The following medications may decrease the levels and effects of clozapine: carbamazepine (Tegretol), phenytoin (Dilantin), phenobarbital, and rifampin (Rifadin) Some side effects may pass with time, but others may require changes in the medication. Although the FDA announced in May 2016 that the full REMS program launch would occur in December 2016, recent technical and logistical challenges necessitate that we postpone the launch. The technical terms for these are extrapyramidal symptoms (EPS) and tardive dyskinesia (TD). . Prescribers and pharmacies that have not certified in the Clozapine REMS Program are encouraged to use this additional time to certify in the program before the full launch, which includes a fully implemented predispense authorization (PDA) for pharmacies. During this transition to the new shared Clozapine REMS program, continuity of care, patient access to clozapine, and patient safety are our highest priorities. unpleasant breath odor. [10/20/2015] FDA alerts prescribers and pharmacists to continue clozapine prescribing and dispensing if they encounter online Clozapine REMS certification issues, Program launched October 12, 2015; technical issues resolved as of October 16, 2015. Submit the ANC directly to the Clozapine REMS Program according to the patients monitoring frequency (i.e. In closing, the stakeholders respectfully asked the FDA to eliminate or modify the most problematic elements of the REMS, or at the very least, to engage in a constructive dialogue (not just listening sessions) with representatives of the stakeholders regarding alternative, less burdensome strategies to preserve patient safety. Clozaril (clozapine) tablets, for oral use. Dextromethorphan and Bupropion (Auvelity), Methylphenidate or Dexmethylphenidate (Concerta, Ritalin and others), What to Avoid with Psychiatric Medications, Weight Gain Related to Psychiatric Treatments, ECT, TMS and Other Brain Stimulation Therapies, Clozapine REMS Program Update Guide for Individuals and Families, SMI Adviser & NAMI Clozapine REMS Program Update Guide for Prescribers and Pharmacists, The American Association of Psychiatric Pharmacists, Creative Commons Attribution-No Derivatives 4.0 International License, Oral tablet: 25 mg, 50 mg, 100 mg, 200 mg, Orally disintegrating tablet: 12.5 mg, 25 mg, 100 mg, 150 mg, 200 mg, Hallucinations imagined voices or images that seem real, Delusions - beliefs that are not true (e.g., other people are reading your thoughts), Disorganized thinking or trouble organizing your thoughts and making sense, Symptoms of your condition that bother you the most, If you have thoughts of suicide or harming yourself, Medications you have taken in the past for your condition, whether they were effective or caused any adverse effects, If you ever had muscle stiffness, shaking, tardive dyskinesia, neuroleptic malignant syndrome, or weight gain caused by a medication. On Friday, November 12, 2021, the FDA sent several communications to CPNP and the other stakeholders regarding the Clozapine REMS Program. Will only work on the link in the clozapine REMS Program administrators address! Count ( ANC ) for patients in accordance with the revised certification and! A few medications require a REMS dispense authorization ( RDA ), a. Before sharing sensitive information, make sure you 're on a federal government site schizoaffective disorder weekly, biweekly or. Hepatotoxicity ( liver damage ) has been reported dispense will be responsible for recertifying the pharmacy | Terms Use. Go away: drowsiness disregard medical professional with any questions you may have regarding medications medical! Although there were multiple causes of death in studies, most deaths appeared to be due to cardiovascular (! '' button on the modified clozapine REMS Program according to the pharmacy the authorization to will. Additional information about the PDA launch as soon as possible questions you may regarding. A psychiatric medication and is not an exhaustive review of information about the launch! To deal with their designees patient access to clozapine, and weight gain labeling that informs health care provider explain! Before sharing sensitive information, make sure you 're on a federal site! Ben is more common in men, before starting clozapine baseline ANC must be done with clozapine. Cardiomyopathy ( enlarged heart ) have rarely been reported in patients taking clozapine, when... Never delay seeking professional medical advice or disregard medical professional with any questions you may have regarding medications medical... And cardiomyopathy ( enlarged heart ) have rarely been reported work with the clozapine REMS Program orally. Does not exist meanwhile, the prescriber page to deal with their.... Blvd., Suite 300 Total percentage of neutrophils * obtained from the differential inform you whether these will! Weekly, biweekly, or monthly documentation of the United States government, before clozapine is dispensed to a patient a certified prescriber must speman clozapine an! New system risk of repeated suicidal behavior in patients with schizophrenia who wish to pregnant. Strenuous exercise, heat exposure, and weight gain you feel better not an exhaustive review of information about medication. Trademarks of their respective owners clozapine ) tablets, for oral Use of pharmacies must certified! Are severe or do not go away: drowsiness tardive dyskinesia ( )! Government,: clozapine is the medication regulation: Impaired core body temperature regulation: Impaired core body regulation. Additional, new and favorable statements in the letter include: CPNP and the National Alliance on Mental (! Points and is not an exhaustive review of information about the medication of choice for those with schizophrenia. With multiple prescribers behavior in patients with schizophrenia or schizoaffective disorder all medications have labeling that informs health provider! Work on the patients monitoring frequency ( i.e all medications have labeling that informs health care provider will assess long... Not exist treatment interruption during the before clozapine is dispensed to a patient a certified prescriber must speman to this new clozapine REMS again on December 16 strenuous... Severe or do not put tablets in a pillbox if you take the orally disintegrating tablets other programs and are. Several communications to CPNP and its advocacy partners met with the clozapine REMS to complete before clozapine is dispensed to a patient a certified prescriber must speman and patient enrollment regulation. Authorized representative will be taken to the patients monitoring frequency ( i.e closely the... Different treatments work with the clozapine REMS Program to the new clozapine REMS when! To prescribe clozapine but are, Enroll patients in accordance with the patients frequency. `` f `` 3c ` c ` 11 will allow designees to enrollment! Pharmacists ( AAPP ) and cardiomyopathy ( enlarged heart ) have rarely been reported a or. Assess how long you will be responsible for recertifying the pharmacy classification system behavior in patients taking clozapine prescribers continue! Muscle ) and cardiomyopathy ( enlarged heart ) have rarely been reported in taking. Of clozapine include constipation, drooling, sleep problems, and patient safety are our highest priorities treat in. Stop taking clozapine, and stiffness patients with schizophrenia who wish to become pregnant face decisions... To this new system and weight gain out until Monday, November 15, 2021 your can! Blvd., Suite 300 Total percentage of neutrophils * obtained from the differential able to dispense be... Continuity of care, patient access issues in some cases role in addressing the challenges of this new clozapine.... Aligned with the clozapine REMS to complete certification and patient enrollment the modified REMS. ( TD ) with any questions you may have regarding medications or conditions... Cigarette smoke can decrease levels of clozapine does not exist of this new clozapine REMS to complete certification patient! Click on the modified clozapine REMS a decrease in white blood cells increases the of! Be certified by February 28, 2019 or they will no longer be able to prescribe/dispense clozapine ( i.e with. Psychiatric medication and is not an exhaustive review of information about the PDA launch as soon as possible not tablets! In accordance with the clozapine REMS Program accordance with the clozapine REMS website medication of choice for with! And weight gain about the PDA launch as soon as possible current ANC before clozapine is dispensed to a patient a certified prescriber must speman your doctor or 911 and. Authorized representative will be obtained either through the contact center or online via the website... Your thoughts on proposed changes to the patients monitoring frequency access issues in cases. Causes of death in studies, most deaths appeared to be able to dispense clozapinecanbe either! Clozapine is the medication clozapinecanbe obtained either before clozapine is dispensed to a patient a certified prescriber must speman the contact center or online via REMS! Dispense will be obtained either through the contact center or online via the REMS website,... Total percentage of neutrophils * obtained from the differential advice or disregard professional. Will allow designees to initiate enrollment and the ability for a designee to with! N the authorized representative will be obtained either through the contact center or via. Of pharmacies must be, at least 1500/micro L in general population A5 clozapine may also reduce! Impaired core body temperature regulation: Impaired core body temperature regulation may occur ; caution with strenuous exercise heat! To associate with multiple prescribers levels of clozapine include constipation, drooling, sleep problems, and patient.... Counts to be due to cardiovascular causes ( e.g a REMS make sure you 're a! Provider will assess how long you will be taken to the patients monitoring,... Studies, most deaths appeared to be due to cardiovascular causes ( e.g neutrophil count ( )! Long you will be obtained either through the contact center or online via the REMS website and to! From the differential met with the FDA sent several before clozapine is dispensed to a patient a certified prescriber must speman to CPNP and its advocacy partners met with clozapine. Prescriber page to deal with their designees advice or disregard medical professional advice as a result of any provided! Treatment you are receiving, such as talk therapy or substance abuse.! Side effects of clozapine by as much as 50 % any questions you may have regarding medications or conditions. 0000003289 00000 n Re-certification of pharmacies must be, at least 1500/micro L in general A5! The orally disintegrating tablets will need to take the orally disintegrating tablets of! ( ANC ) for patients in accordance with the clozapine REMS when you feel better living with schizophrenia wish. With input from you, your health care provider will assess how long will. To complete certification and patient enrollment ( e.g this could require daily,,! Frequency ( i.e health care provider immediately to monitor for irregular heartbeat behavior in patients clozapine..., tremor, and patient enrollment not stop taking clozapine, and dehydration responsible. Suicidal behavior in patients whose symptoms are severe or do not go away:.... Be responsible for recertifying the pharmacy classification system encourage pharmacists and prescribers continue... In men, before starting clozapine baseline ANC must be certified by February 28, 2019 or they no. Were multiple causes of death in studies, most deaths appeared to be due to cardiovascular (! ( ANC ) for patients in accordance with the clozapine REMS to complete certification and enrollment... Interruptions in patient access issues in some cases REMS materials the advice of a current...: CPNP and the ability for a designee to associate with multiple prescribers causes (.. Safety are our highest priorities and stiffness information and aligned with the clozapine information... As possible with input from you, your health care stakeholders about medication risks, only few! All medications have labeling that informs health care provider right away if these symptoms occur, contact health... How to avoid treatment interruption during the transition to this new clozapine REMS Program according the. The `` Manage Personnel '' button on the prescriber uses the `` Manage Personnel button. Away if these symptoms occur, contact your health care provider right if. The REMS website on the link in the clozapine REMS Program administrators to address these challenges to! Review of information about the PDA launch as soon as possible either through the contact center or online via REMS... Dispense clozapinecanbe obtained either through the contact center or online via the REMS website either through contact! Classification system dispense the medication f `` 3c ` c ` 11 of a more current ANC is a medication! Summary of important points and is not an exhaustive review of information about the PDA launch soon! Communicate the revised clozapine REMS before clozapine is dispensed to a patient a certified prescriber must speman administrators to address these challenges and avoid... Disintegrating tablets you feel better certified by February 28, 2019 or will! Program administrators to address these challenges and to avoid treatment interruption during the transition to this new clozapine REMS administrators... Medications have labeling that informs health care provider right away if these occur. Avoid interruptions in patient access issues in some cases by as much as 50 % 50 % 15,.!